from left to right: M. Schrappe, W.-D. Ludwig, G. Glaeske, S. Kapferer (Source: BMG)The professors Klaus Höffken, Wolf-Dieter Ludwig, Matthias Schrappe, Lothar Weißbach and Eberhard Wille, as well as the research fellows Maike Rehrmann and Friederike Höfel were involved as experts.
The Onkology-Report was commissioned by the Federal Ministry of Health in 2009 within the National Cancerplan. Besides an extended review of the developements in oncological pharmacotherapy regarding medical and economic aspects, the pharmaceutical and social law, the authors suggest strategies to secure an efficient and evidence-based pharmacological treatment. Furthermore, concepts were introduced for differentiated financing of the expensive oncological drugs. In addition to research on the benefit of these drugs in health care reality, the patient orientation was strengthened by presenting strategies for the provision of neutral information.
The report provides an important basis for discussions and the work of the National Cancerplan.
Download (in German):
Press release from 11th January 2011, Bundesministerium für Gesundheit
Expertise (in German):
Glaeske, Gerd; Rehrmann, Maike; Höffken, Klaus; Ludwig, Wolf-Dieter; Schrappe, Matthias; Weißbach, Lothar; Wille, Eberhard, 2010: Sicherstellung einer effizienten Arzneimittelversorgung in der Onkologie, on behalf of: Bundesministerium für Gesundheit, Berlin, 11.01.2011
Contact:
Prof. Dr. Gerd Glaeske (verstorben)
Dipl.-Soz. Friederike Höfel
